4.6 Article

Combinatorial Expression of NK Cell Receptors Governs Cell Subset Reactivity and Effector Functions but Not Tumor Specificity

期刊

JOURNAL OF IMMUNOLOGY
卷 208, 期 7, 页码 1802-1812

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.2100874

关键词

-

向作者/读者索取更多资源

The combination of NK cell receptors does not affect the hierarchy of NK cell responses to different tumor types, but rather influences their intrinsic reactivities. Coexpression of specific receptors can identify NK cell subsets with relative cytotoxic specialization, while other receptors are more suitable for IFN-γ production.
NK cell receptors allow NK cells to recognize targets such as tumor cells. Many of them are expressed on a subset of NK cells, independently of each other, which creates a vast diversity of receptor combinations. Whether these combinations influence NK cell antitumor responses is not well understood. We addressed this question in the C57BL/6 mouse model and analyzed the individual effector response of 444 mouse NK cell subsets, defined by combinations of 12 receptors, against tumor cell lines originating from different tissues and mouse strains. We found a wide range of reactivity among NK subsets, but the same hierarchy of responses was observed for the different tumor types, showing that the repertoire of NK cell receptors does not encode for different tumor specificities but for different intrinsic reactivities. The coexpression of CD27, NKG2A, and DNAM-1 identified subsets with relative cytotoxic specialization, whereas reciprocally, CD11b and KLRG1 defined the best IFN-'y producers. The expression of educating receptors Ly49C, Ly49I, and NKG2A was also strongly correlated with IFN-'y production, but this effect was suppressed by unengaged receptors Ly49A, Ly49F, and Ly49G2. Finally, IL-15 coordinated NK cell effector functions, but education and unbound inhibitory receptors retained some influence on their response. Collectively, these data refine our understanding of the mechanisms governing NK cell reactivity, which could help design new NK cell therapy protocols. The Journal of Immunology, 2022, 208: 1802-1812.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据